Trials / Unknown
UnknownNCT04261179
Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer
An Exploratory Prospective, Open-label, Unicentric Study With Cross-over Design, Comparing Lymphoseek® vs. Albumin Nanocolloid for Image- Guided Sentinel Lymph Node Mapping in Head and Neck, Melanoma and Breast Cancer.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Anna Cruceta · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of the concordance of albumin nanocolloid and Lymphoseek® in the detection of lymph nodes of primary and secondary stage drainage by performing two lymphogammagrams
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lymphoseek | 50 μg microgram(s), timepoint: 30-60 minutes |
| DRUG | Nanocoll | 500 μg microgram(s), timepoint: 30-60 minutes |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2021-02-01
- Completion
- 2021-08-01
- First posted
- 2020-02-07
- Last updated
- 2020-02-20
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04261179. Inclusion in this directory is not an endorsement.